MetLife Investment Management’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $152K | Hold |
10,093
| – | – | ﹤0.01% | 2329 |
|
|
2025
Q1 | $162K | Hold |
10,093
| – | – | ﹤0.01% | 2305 |
|
|
2024
Q4 | $176K | Hold |
10,093
| – | – | ﹤0.01% | 2360 |
|
|
2024
Q3 | $177K | Hold |
10,093
| – | – | ﹤0.01% | 2351 |
|
|
2024
Q2 | $113K | Buy |
10,093
+988
| +11% | +$11.1K | ﹤0.01% | 2549 |
|
|
2024
Q1 | $79.3K | Hold |
9,105
| – | – | ﹤0.01% | 2633 |
|
|
2023
Q4 | $111K | Buy |
+9,105
| New | +$111K | ﹤0.01% | 2556 |
|
|
2021
Q4 | – | Sell |
-5,276
| Closed | -$114K | – | 2540 |
|
|
2021
Q3 | $114K | Buy |
+5,276
| New | +$114K | ﹤0.01% | 2385 |
|
|
2021
Q2 | – | Sell |
-6,647
| Closed | -$157K | – | 2476 |
|
|
2021
Q1 | $157K | Hold |
6,647
| – | – | ﹤0.01% | 2173 |
|
|
2020
Q4 | $159K | Buy |
+6,647
| New | +$159K | ﹤0.01% | 2103 |
|